104 related articles for article (PubMed ID: 10599348)
1. Pyridinium crosslinks excretion in patients with rheumatoid arthritis. Correlation with disease activity and glucocorticoid treatment.
Xuereb Anastasi A; Buhagiar A; Camilleri F; Cauchi M; Mallia C
Adv Exp Med Biol; 1999; 455():227-33. PubMed ID: 10599348
[TBL] [Abstract][Full Text] [Related]
2. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis.
Gough AK; Peel NF; Eastell R; Holder RL; Lilley J; Emery P
Ann Rheum Dis; 1994 Jan; 53(1):14-7. PubMed ID: 8311548
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis.
Astbury C; Bird HA; McLaren AM; Robins SP
Br J Rheumatol; 1994 Jan; 33(1):11-5. PubMed ID: 8162449
[TBL] [Abstract][Full Text] [Related]
4. Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone.
Stichtenoth DO; Fauler J; Zeidler H; Frölich JC
Ann Rheum Dis; 1995 Oct; 54(10):820-4. PubMed ID: 7492221
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis.
Black D; Marabani M; Sturrock RD; Robins SP
Ann Rheum Dis; 1989 Aug; 48(8):641-4. PubMed ID: 2490853
[TBL] [Abstract][Full Text] [Related]
6. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
[TBL] [Abstract][Full Text] [Related]
7. The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis.
Hein G; Franke S; Müller A; Bräunig E; Eidner T; Stein G
Clin Rheumatol; 1997 Mar; 16(2):167-72. PubMed ID: 9093799
[TBL] [Abstract][Full Text] [Related]
8. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
[TBL] [Abstract][Full Text] [Related]
9. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
[TBL] [Abstract][Full Text] [Related]
10. [Collagen breakdown in ankylosing spondylitis-relationship to disease related parameters].
Bölzner C; Müller A; Bräunig E; Hein G
Z Rheumatol; 2003 Oct; 62(5):459-67. PubMed ID: 14579033
[TBL] [Abstract][Full Text] [Related]
11. Standardized grip strength as an outcome measure in early rheumatoid arthritis.
Sheehy C; Gaffney K; Mukhtyar C
Scand J Rheumatol; 2013; 42(4):289-93. PubMed ID: 23311733
[TBL] [Abstract][Full Text] [Related]
12. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
Wolfe F
J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
[TBL] [Abstract][Full Text] [Related]
13. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis.
Crowson CS; Rahman MU; Matteson EL
J Rheumatol; 2009 Aug; 36(8):1606-10. PubMed ID: 19531760
[TBL] [Abstract][Full Text] [Related]
14. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
[TBL] [Abstract][Full Text] [Related]
15. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
Keenan RT; Swearingen CJ; Yazici Y
Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813
[TBL] [Abstract][Full Text] [Related]
17. The timing of glucocorticoid administration in rheumatoid arthritis.
Arvidson NG; Gudbjörnsson B; Larsson A; Hällgren R
Ann Rheum Dis; 1997 Jan; 56(1):27-31. PubMed ID: 9059137
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study.
Drosos AA; Voulgari PV; Papadopoulos IA; Politi EN; Georgiou PE; Zikou AK
Clin Exp Rheumatol; 1998; 16(6):695-701. PubMed ID: 9844762
[TBL] [Abstract][Full Text] [Related]
19. Effect of acute and chronic glucocorticoid therapy on insulin sensitivity and postprandial vascular function.
Radhakutty A; Mangelsdorf BL; Drake SM; Samocha-Bonet D; Jenkins AB; Heilbronn LK; Smith MD; Thompson CH; Burt MG
Clin Endocrinol (Oxf); 2016 Apr; 84(4):501-8. PubMed ID: 26493042
[TBL] [Abstract][Full Text] [Related]
20. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group.
Kirwan JR
N Engl J Med; 1995 Jul; 333(3):142-6. PubMed ID: 7791815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
